News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Lonza Group Ltd. to Invest $150 Million in Genome Valley
May 22, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PharmaBiz -- Switzerland-based Lonza, one of the global biopharmaceutical giants, would make an investment of US $150 million (around Rs 750 crore) for two major projects in Genome Valley, which is located at the outskirts of Hyderabad.
Twitter
LinkedIn
Facebook
Email
Print
Asia
Lonza
MORE ON THIS TOPIC
Podcast
Lilly’s Obesity Pill Heads to the FDA, AbbVie Bets on Psychedelics, HHS Unveils More Change
August 27, 2025
·
1 min read
·
Jef Akst
China
Pharma Spent More Than $48B in China in H1, Eclipsing Total 2024 Haul
August 27, 2025
·
2 min read
·
Annalee Armstrong
IN PARTNERSHIP WITH CRESSET
Why AI Won’t Save the 90% of Clinical Trials That Still Fail
August 21, 2025
·
1 min read
·
Lori Ellis
IN PARTNERSHIP WITH CRESSET
From Chat Bots to World Order: The Race for the 21st Century’s Operating System
August 7, 2025
·
1 min read
·
Lori Ellis
